KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Other Working Capital Changes: 2012-2024

Historic Other Working Capital Changes for Sarepta Therapeutics (SRPT) over the last 13 years, with Dec 2024 value amounting to -$32.2 million.

  • Sarepta Therapeutics' Other Working Capital Changes rose 100.47% to $159.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 47.81%. This contributed to the annual value of -$32.2 million for FY2024, which is 62.96% up from last year.
  • Latest data reveals that Sarepta Therapeutics reported Other Working Capital Changes of -$32.2 million as of FY2024, which was up 62.96% from -$86.8 million recorded in FY2023.
  • In the past 5 years, Sarepta Therapeutics' Other Working Capital Changes ranged from a high of $749.4 million in FY2020 and a low of -$103.2 million during FY2021.
  • Over the past 3 years, Sarepta Therapeutics' median Other Working Capital Changes value was -$86.8 million (recorded in 2023), while the average stood at -$69.4 million.
  • As far as peak fluctuations go, Sarepta Therapeutics' Other Working Capital Changes surged by 634.08% in 2020, and later tumbled by 113.77% in 2021.
  • Over the past 5 years, Sarepta Therapeutics' Other Working Capital Changes (Yearly) stood at $749.4 million in 2020, then slumped by 113.77% to -$103.2 million in 2021, then grew by 13.53% to -$89.2 million in 2022, then rose by 2.71% to -$86.8 million in 2023, then skyrocketed by 62.96% to -$32.2 million in 2024.